13F HOLDINGS REPORT
Catalys Pacific, LLC
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001104659-25-077546
Total Value
$131.7M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 8,903,838 | $120.5M | 91.50% |
| 2 | Phathom Pharmaceuticals, Inc. | PHAT | 1,167,114 | $11.2M | 8.50% |